Skip to main content
Alamar Biosciences, Inc. (ALMR)
NASDAQ: ALMR · Real-Time Price · USD
30.24
-1.52 (-4.79%)
Nov 13, 2026, 11:35 AM EST - Market open

Alamar Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Net Income
-55-29.82-47.07
Depreciation & Amortization
3.72.762.29
Other Amortization
1.371.290.98
Loss (Gain) From Sale of Investments
-0.54-0.12-1.89
Stock-Based Compensation
9.532.870.87
Other Operating Activities
13.191.981.59
Change in Accounts Receivable
-10.9-5.5-5.1
Change in Inventory
-22.12-23.78-8.75
Change in Accounts Payable
6.73-0.572.92
Change in Other Net Operating Assets
-6.99-2.72-1.06
Operating Cash Flow
-60.92-53.61-55.21
Operating Cash Flow Growth
---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Capital Expenditures
-7.55-5.37-2.95
Sale (Purchase) of Intangibles
-0.58-1.01-0.44
Investment in Securities
-104.6952.56-50.55
Investing Cash Flow
-112.8146.18-53.93

Financing Activities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Long-Term Debt Issued
-10-
Long-Term Debt Repaid
---15
Net Debt Issued (Repaid)
40.3510-15
Issuance of Common Stock
208.471.490.94
Other Financing Activities
-1.04-0.66-
Financing Cash Flow
247.7810.84113.42

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Foreign Exchange Rate Adjustments
-0.16-0.17-0
Net Cash Flow
73.893.234.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Free Cash Flow
-68.47-58.98-58.16
Free Cash Flow Growth
---
Free Cash Flow Margin
-60.03%-79.48%-231.33%
Free Cash Flow Per Share
-1.79-5.11-4.89
Levered Free Cash Flow
--49.7-
Unlevered Free Cash Flow
--49.65-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash Interest Paid
0.690.132.05
Change in Working Capital
-33.29-32.57-11.99
SEC Filings: 10-K · 10-Q